Ichthyosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Condition:   Congenital Ichthyosis Interventions:   Drug: PAT-001, 0.1%;   Drug: PAT-001, 0.2%;   Drug: Vehicle Sponsor:   Patagonia Pharmaceuticals, LLC Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2016 Category: Research Source Type: clinical trials